• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再次探讨无心跳供体的临床肺移植。

Clinical lung transplantation from uncontrolled non-heart-beating donors revisited.

机构信息

Department of Thoracic Surgery, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

出版信息

J Heart Lung Transplant. 2012 Apr;31(4):349-53. doi: 10.1016/j.healun.2011.12.007. Epub 2012 Feb 3.

DOI:10.1016/j.healun.2011.12.007
PMID:22306439
Abstract

BACKGROUND

The aim of our study is to review and update the long-term results from our previously published series of lung transplantation in uncontrolled non-heart-beating donors (NHBDs).

METHODS

A prospective collection of data was undertaken from all lung transplants performed among uncontrolled NHBDs between 2002 and December 2009. The statistical analysis was performed using SPSS software and survival was estimated using the Kaplan-Meier method.

RESULTS

Twenty-nine lung transplants were performed. Mean total ischemic times for the first and second lung were 575 minutes (SD 115.6) and 701 minutes (SD 111.3), respectively. Primary graft dysfunction (PGD) G1, G2 and G3 occurred in 5 cases (17%), 5 cases (17%) and 11 cases (38%), respectively. Overall hospital mortality rate was 17% (5 patients). Statistical analysis revealed a statistically significant association of mortality with ischemic times and with PGD. In terms of overall survival, 3-month, 1-year, 2-year and 5-year survival rates were 78%, 68%, 57% and 51%, respectively, and the conditional survival rates in those who survived the first 3 months were 86%, 72% and 65%, respectively. The cumulative incidence of bronchiolitis obliterans syndrome (BOS) was 11%, 35% and 45% at 1, 3 and 5 years, respectively.

CONCLUSIONS

Lung transplantation from uncontrolled non-heart-beating donors shows acceptable results for both mid- and long-term survival and BOS; however, the higher rates of PGD and its impact on early mortality must make us more demanding with respect to the acceptance criteria and methods of evaluation used with these donors.

摘要

背景

本研究旨在回顾和更新我们之前发表的非心脏死亡供者(NHBD)肺移植系列研究的长期结果。

方法

前瞻性收集 2002 年至 2009 年 12 月间所有非控制型 NHBD 肺移植患者的数据。使用 SPSS 软件进行统计学分析,采用 Kaplan-Meier 方法估计生存率。

结果

共进行了 29 例肺移植。第一和第二肺的总缺血时间分别为 575 分钟(SD 115.6)和 701 分钟(SD 111.3)。原发性移植物功能障碍(PGD)G1、G2 和 G3 分别发生在 5 例(17%)、5 例(17%)和 11 例(38%)中。总住院死亡率为 17%(5 例)。统计分析显示,死亡率与缺血时间和 PGD 有显著相关性。在总体生存方面,3 个月、1 年、2 年和 5 年生存率分别为 78%、68%、57%和 51%,而在存活 3 个月以上的患者中,其生存率分别为 86%、72%和 65%。1 年、3 年和 5 年时,闭塞性细支气管炎综合征(BOS)的累积发生率分别为 11%、35%和 45%。

结论

来自非心脏死亡供者的肺移植在中、长期生存和 BOS 方面具有可接受的结果;然而,PGD 的较高发生率及其对早期死亡率的影响,使得我们对这些供者的接受标准和评估方法的要求更加严格。

相似文献

1
Clinical lung transplantation from uncontrolled non-heart-beating donors revisited.再次探讨无心跳供体的临床肺移植。
J Heart Lung Transplant. 2012 Apr;31(4):349-53. doi: 10.1016/j.healun.2011.12.007. Epub 2012 Feb 3.
2
Results of clinical lung transplant from uncontrolled non-heart-beating donors.非心脏跳动供体的临床肺移植结果。
J Heart Lung Transplant. 2007 May;26(5):529-34. doi: 10.1016/j.healun.2007.01.028.
3
Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors.脑死亡和心死亡供者的肺移植中期结果相当。
J Heart Lung Transplant. 2011 Sep;30(9):975-81. doi: 10.1016/j.healun.2011.04.014. Epub 2011 Jun 12.
4
Early lung retrieval from traumatic brain-dead donors does not compromise outcomes following lung transplantation.从创伤性脑死亡供体中早期获取肺脏不会影响肺移植后的结果。
Eur J Cardiothorac Surg. 2013 Jun;43(6):e190-7. doi: 10.1093/ejcts/ezt033. Epub 2013 Feb 20.
5
[Lung transplantation with uncontrolled non-heart-beating donors. Transplantation. Donor prognostic factor and immediate evolution post transplant].[使用非心脏跳动供体且情况未得到控制的肺移植。移植。供体预后因素及移植后的即刻病情进展]
Arch Bronconeumol. 2011 Aug;47(8):403-9. doi: 10.1016/j.arbres.2011.04.009. Epub 2011 Jun 21.
6
The use of non-heart-beating lung donors category III can increase the donor pool.使用非心搏供体 III 类可增加供体池。
Eur J Cardiothorac Surg. 2011 Jun;39(6):e175-80; discussion e180. doi: 10.1016/j.ejcts.2011.01.035. Epub 2011 Mar 3.
7
Twinned single-lung transplantation: a privileged model for the study of recipient-dependent factors of outcome.孪生单肺移植:研究受体相关因素对结局影响的特权模型。
Eur J Cardiothorac Surg. 2012 Jun;41(6):1357-64; discussion 1364-5. doi: 10.1093/ejcts/ezr234. Epub 2012 Jan 12.
8
Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.1997年至1999年在欧洲移植组织进行的所有连续单纯心脏移植和单纯肺移植的三年生存率。
Clin Transpl. 2003:89-100.
9
Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center.心肺死亡后捐献供者的肺移植:单中心的长期随访。
J Thorac Cardiovasc Surg. 2010 May;139(5):1306-15. doi: 10.1016/j.jtcvs.2010.02.004.
10
Primary graft dysfunction and long-term pulmonary function after lung transplantation.肺移植后的原发性移植肺功能障碍和长期肺功能
J Heart Lung Transplant. 2007 Oct;26(10):1004-11. doi: 10.1016/j.healun.2007.07.018.

引用本文的文献

1
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review.脑死亡和心源性死亡供体肺脏利用率最大化策略:一篇叙述性综述
J Clin Med. 2025 Jul 30;14(15):5380. doi: 10.3390/jcm14155380.
2
Update in lung transplantation: anesthetic considerations.肺移植最新进展:麻醉相关考量
Ann Transl Med. 2023 Oct 25;11(11):389. doi: 10.21037/atm-22-4602. Epub 2023 Jul 6.
3
Uncontrolled Donation after Circulatory Death Only Lung Program: An Urgent Opportunity.循环死亡后器官捐献仅肺脏项目:一个紧迫的机遇。
J Clin Med. 2023 Oct 12;12(20):6492. doi: 10.3390/jcm12206492.
4
Thoracic surgery in Spain.西班牙的胸外科手术。
J Thorac Dis. 2022 Mar;14(3):779-787. doi: 10.21037/jtd-21-1108.
5
Mesenchymal Stromal/Stem Cells and Their Products as a Therapeutic Tool to Advance Lung Transplantation.间充质基质/干细胞及其产物作为推进肺移植的治疗工具。
Cells. 2022 Feb 27;11(5):826. doi: 10.3390/cells11050826.
6
Donation after circulatory death donors in lung transplantation.循环死亡后器官捐献供体在肺移植中的应用
J Thorac Dis. 2021 Nov;13(11):6536-6549. doi: 10.21037/jtd-2021-13.
7
Extended-criteria uncontrolled DCD donor for a fragile recipient: A case report about a challenging yet successful lung transplantation.为脆弱受者提供的扩展标准非控制性脑死亡供体:一例关于具有挑战性但成功的肺移植的病例报告。
Int J Surg Case Rep. 2020;77S(Suppl):S67-S71. doi: 10.1016/j.ijscr.2020.09.051. Epub 2020 Sep 14.
8
Developments in lung transplantation over the past decade.过去十年间肺移植的发展。
Eur Respir Rev. 2020 Jul 21;29(157). doi: 10.1183/16000617.0132-2019. Print 2020 Sep 30.
9
Organ donation after circulatory death: current status and future potential.循环死亡后器官捐献:现状与未来潜能。
Intensive Care Med. 2019 Mar;45(3):310-321. doi: 10.1007/s00134-019-05533-0. Epub 2019 Feb 6.
10
Historical perspectives of lung transplantation: connecting the dots.肺移植的历史视角:串连起各个要点。
J Thorac Dis. 2018 Jul;10(7):4516-4531. doi: 10.21037/jtd.2018.07.06.